Q4 2020 13F Holders as of 31 Dec 2020
-
Type / Class
-
Equity / U.S. PHARMA ETF
-
Total 13F shares
-
506,263
-
Share change
-
+20,058
-
Total reported value
-
$90,864,669
-
Price per share
-
$179.44
-
Number of holders
-
96
-
Value change
-
+$3,773,491
-
Number of buys
-
44
-
Number of sells
-
33
Institutional Holders of ISHARES TR - U.S. PHARMA ETF (IHE) as of Q4 2020
As of 31 Dec 2020,
ISHARES TR - U.S. PHARMA ETF (IHE) was held by
96 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
506,263 shares.
The largest 10 holders included
MORGAN STANLEY, BROWN ADVISORY INC, ROYAL BANK OF CANADA, Tower Research Capital LLC (TRC), BANK OF AMERICA CORP /DE/, RAYMOND JAMES & ASSOCIATES, LPL Financial LLC, WELLS FARGO & COMPANY/MN, MURPHY CAPITAL MANAGEMENT INC, and Steward Partners Investment Advisory, LLC.
This page lists
97
institutional shareholders reporting positions in this security
for the Q4 2020 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.